Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)

KPMG's Mayor Says OPEC Needs New Strategy on Shale
18:41 - Regina Mayor, global sector head of energy and natural resources at KMPG, talks about the market impact of OPEC production cuts and the ability of U.S. shale producers to combat the cuts. She speaks with Bloomberg's Alix Steel on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
  • El-Erian Says Don't Ignore Slow Growth
  • Vanguard's McNabb on China Expansion, U.S. Markets
  • Vanguard's McNabb Sees Optimism for China Expansion